Having trouble accessing articles? Reset your cache.

Anthera planning $31.5M unit sale

Anthera Pharmaceuticals Inc. (NASDAQ:ANTH) plans to raise $31.5 million through the

Read the full 117 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE